Nasdaq 100 Stocks SEC Filings — October 08, 2026

Q3 2026 net revenue +5.6% YoY to $25.274B, organic +3.1%, EPS $2.23 (+17% YoY), and YTD net income +46.6% to $8.356B

Core operating margin contracted 35 bps to 16.9% and core EPS grew only ~2%, showing earnings quality weaker than headline growth suggests

Full-year core EPS guidance cut to +2.5-3.5% from +5-7% citing input cost inflation, a material downward revision that likely pressures estimates

Operating cash flow rose to $7.950B from $5.468B YoY, a strong cash-generation signal that supports dividend and balance-sheet capacity

Net cash used in financing rose to $3.904B from $1.008B YoY, indicating heavier capital returns or debt activity that bears monitoring

Net currency translation loss of $858M in the quarter vs a $39M gain a year earlier, a sizable FX headwind to comprehensive income

Growth benefited from a 1.7-ppt acquisition/divestiture contribution and mark-to-market commodity gains, so underlying organic momentum (+3.1%) is less than headline growth

Director STATA RAY sold ~$295K at $420.30 under a Rule 10b5-1 plan across 11 transactions, retaining 107,431 shares; pre-scheduled plan limits conviction signal

SVP/GC Newstead Jennifer sold 2,399 shares at $332.01 (~$796K) under a Rule 10b5-1 plan, retaining 39,593 shares; routine plan-based selling, low signal weight

Director Boone Karen exercised 1,460 Class A shares and RSUs, holding 10,240 shares post-transaction; equity-compensation activity rather than open-market selling

CFO Agrawal Nitin sold only 3 shares (~$266) under a 10b5-1 plan, retaining 132,596 shares; immaterial in size and not a meaningful conviction signal

Full-year core EPS guidance lowered to +2.5-3.5% from +5-7%, a roughly 300-350 bps reduction that resets expectations materially

Core operating margin down 35 bps to 16.9% YoY while input cost inflation is rising, with management signaling need for further structural cost cuts

Reported operating profit +19% and net income surge were aided by acquisition/divestiture charge netting and commodity derivative mark-to-market gains, not purely operations

$858M quarterly currency translation loss (vs $39M gain prior year) materially reduces comprehensive income and highlights international currency sensitivity

Net financing cash use up to $3.904B from $1.008B YoY, nearly quadrupling, raising questions on debt levels and sustainability of payouts

Unallocated corporate expenses of $386M in the quarter add to cost pressure ahead of the planned structural reduction program

Senior executive sale of ~$796K, though under a 10b5-1 plan, adds to a steady pattern of executive distribution that some investors read negatively

Repeated director sales across multiple price points ($418-$421) over 11 transactions show consistent distribution, though plan-driven

Management's explicit cost-reduction push, combined with strong operating cash flow ($7.950B YTD), positions the company to rebuild core margin if input inflation eases

Guidance cut to +2.5-3.5% core EPS growth may have de-rated shares; a stabilizing margin trajectory would support recovery in multiple

Management cited international strength as a driver of Q3 growth, a durable diversification advantage vs North America-focused peers

Improved North America convenient foods volume trends are an early-stage positive signal for organic growth re-acceleration

Operating cash flow nearly 45% above prior year at $7.950B YTD provides funding optionality for buybacks, dividends, or bolt-on M&A

Director and CFO holdings retained post-transaction (10,240 and 132,596 shares), with minimal open-market selling, supporting management alignment

Director retained 107,431 shares after multi-tranche sales, indicating a meaningful residual stake despite distribution

PepsiCo's core margin fell 35 bps and guidance was cut on rising input costs, a pattern that likely affects packaged-food and beverage peers with similar commodity exposure

PepsiCo's +17% EPS and +46.6% YTD net income contrast with ~2% core EPS growth, showing non-operating items (derivative gains, divestiture effects, absence of prior impairments) inflating reported results

The $858M translation loss versus a prior-year gain underscores FX as a significant earnings and comprehensive-income swing factor for global NASDAQ-100 constituents

Analog Devices, Apple and CoreWeave sales were all executed under 10b5-1 plans, suggesting pre-scheduled diversification rather than discretionary sell signals across this cohort

PepsiCo's financing outflows nearly quadrupled YoY while operating cash rose, indicating cash generation is being redeployed into shareholder returns or debt management

Details and timing of additional cost reductions promised with the guidance cut; watch next earnings release for quantified savings and any restructuring charges

Whether Q4 2026 core operating margin stabilizes after the 35 bps Q3 contraction; key input is commodity cost trend and pricing action

Sources and uses behind the $3.904B financing outflow (buybacks vs debt repayment vs dividends) and implications for leverage

Continued currency translation drag in coming quarters given the $858M Q3 loss; monitor major emerging-market currency moves

Follow-on Form 4 filings to see whether the CFO's minimal sale or director exercises expand into larger open-market transactions

Watch whether the 10b5-1 sales by director STATA RAY continue at similar pricing (~$418-$421) and whether holdings decline materially below 107,431 shares

Monitor further 10b5-1 sales by Newstead Jennifer and whether the pattern extends to other senior officers around current price levels near $332